Core Viewpoint - iFlytek Medical Technology (02506) has seen a stock increase of over 4%, currently trading at 78.35 HKD with a transaction volume of 7.8092 million HKD, indicating positive market sentiment towards the company following recent announcements [1] Group 1: Shareholder Commitment - Eight shareholders, including iFlytek (002230) and Kexin Venture Capital, have committed not to reduce their holdings of H-shares or unlisted shares until December 29, 2026, enhancing investor confidence [1] - These eight shareholders collectively hold 55.7584 million H-shares, representing 68.25% of the total H-share capital, and a total of 88.0682 million shares, accounting for 72.86% of the company's total share capital [1] Group 2: Strategic Partnership - iFlytek Medical has signed a strategic cooperation agreement with the Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, marking a significant milestone in the company's expansion in the smart healthcare sector [1] - This partnership is seen as a new opportunity for the hospital to achieve technological upgrades through collaboration with iFlytek Medical [1]
讯飞医疗科技再涨超4% 8名股东自愿延长禁售 智慧医疗领域持续拓展